ABBOTINDIA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Abbott India reported strong Q4 FY26 results with total income of ₹1,785.10 crore, up 6.2% from ₹1,680.61 crore in Q4 FY25. Net profit after tax grew 7.6% to ₹394.93 crore. For the full year FY26, total income reached ₹7,217.19 crore versus ₹6,684.73 crore in FY25, representing 8% growth. Net profit after tax for FY26 stood at ₹1,552.02 crore, up 9.7% from ₹1,414.44 crore. Earnings per share improved to ₹730.36 for FY26 from ₹665.62 in FY25. Reserves grew to ₹4,752.94 crore.
The company delivered solid double-digit profit growth with strong operational performance across both quarterly and annual periods. Positive earnings surprise could support the stock price in the near term, indicating robust demand for pharmaceutical products.